COVID-19 大流行期间镰状细胞贫血儿童照护模式的改变。
Changes in Care Delivery for Children With Sickle Cell Anemia During the COVID-19 Pandemic.
机构信息
Division of Pediatric Hematology and Oncology.
College of Nursing.
出版信息
J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1231-e1234. doi: 10.1097/MPH.0000000000002008.
BACKGROUND
Specialty care for children with sickle cell disease (SCD) may be disrupted during the coronavirus (COVID-19) pandemic. Our DISPLACE consortium includes 28 pediatric SCD centers.
METHODS
In May 2020, we surveyed the consortium on the impact of COVID-19 on their practice focusing on transcranial Doppler ultrasound, chronic red cell transfusions, telehealth, and COVID-19 testing.
OBSERVATION
Twenty-four DISPLACE providers completed the survey. Transcranial Doppler ultrasound screening decreased to 67% but chronic red cell transfusions remained at 96%. Most investigators (92%) used telehealth and 40% of providers had patients test positive for COVID-19.
CONCLUSION
The COVID-19 pandemic has affected routine care and necessitated changes in practice in SCD.
背景
在冠状病毒（COVID-19）大流行期间，镰状细胞病（SCD）儿童的专科护理可能会受到影响。我们的 DISPLACE 联盟包括 28 个儿科 SCD 中心。
方法
2020 年 5 月，我们对联盟进行了调查，重点关注 COVID-19 对他们实践的影响，包括经颅多普勒超声、慢性红细胞输注、远程医疗和 COVID-19 检测。
观察结果
24 名 DISPLACE 提供者完成了调查。经颅多普勒超声筛查降至 67%，但慢性红细胞输注仍为 96%。大多数研究人员（92%）使用远程医疗，40%的提供者的患者 COVID-19 检测呈阳性。
结论
COVID-19 大流行影响了 SCD 的常规护理，并需要改变实践。
Zotero 插件